ArticleBioinformatics (Oxford, England)2026
ABAG-Rank: improving model selection of AlphaFold antibody-antigen complexes by learning to rank.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Benchmarking AlphaFold and related deep learning approaches for modeling antibody and TCR antigen recognition.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationAlphaFold has transformed structural biology with an unprecedented accuracy in modelling protein structures and their interactions with biomolecules, with AlphaFold3 (AF3) achieving state-of-the-art performance. However, AF3 and other methods often struggle to accurately predict the structure of protein complexes that lack strong co-evolutionary information, such as antibody-antigen (Ab-Ag) complexes. One of the fundamental issues is that AF3 often generates accurate predictions, but fails to reliably distinguish them from the much larger set of incorrect ones.
resultsTo address this, we propose ABAG-Rank, a deep neural network that provides an efficient and robust solution for model selection of Ab-Ag interactions from a pool of structural ensembles predicted with AlphaFold. Built on the permutation-invariant DeepSets architecture, ABAG-Rank can process variable-sized ensembles of structural decoys and is directly applicable to prediction settings in which the number of candidates may vary. We train a model on a redundancy-reduced set of all known antibody-antigen complexes and find that simple geometric descriptors, along with confidence scores from AlphaFold, provide rich information about interface quality without requiring intensive physics-based calculations. Our experiments demonstrate that ABAG-Rank significantly outperforms AF3 internal scoring and the ranking performance of existing deep learning baselines. AVAILABILITY AND IMPLEMENTATION: Source code can be found at: https://github.com/tadteo/ABAG-Rank or on Zenodo at https://doi.org/10.5281/zenodo.21132090.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.